Nephros (NEPH) Common Equity (2010 - 2026)
Nephros' Common Equity was $11.97 million in Q2 2026, up 24.7% from $9.6 million a year earlier and up 11.8% from the prior quarter.
Powered by 
Analysis
Nephros (NEPH) Common Equity (2010 - 2026) Analysis & Trends
At the end of FY2025, Common Equity at Nephros came in at $10.2 million, up 18.8% from FY2024.
- Common Equity shows a five-year compound annual growth rate of -8.1% (FY2020 to FY2025).
- In earlier years, Common Equity was $8.59 million in FY2024 (+2.7%), $8.36 million in FY2023 (-5.9%), $8.88 million in FY2022 (-39.8%) and $14.75 million in FY2021 (-5.3%).
- The Q2 2026 figure marks the highest quarterly Common Equity since Q2 2022.
- Compared with a year earlier, Common Equity has increased for seven straight quarters, with growth averaging 14.2% over the last eight quarters.
- The best year-over-year quarter for Common Equity over five years was Q3 2021 (growth of 34.0%); the worst was Q4 2022 (a decline of 39.8%).
- Per Business Quant data, NEPH's Common Equity in the three quarters before Q2 2026 was $10.7 million (Q1 2026), $10.2 million (Q4 2025) and $10.01 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 250.06 Bn | 229.21 Bn | 4.88 Bn | 52.69 Bn |
| 2 | Abbott Laboratories | 177.62 Bn | 148.71 Bn | 7.27 Bn | 51.76 Bn |
| 3 | Danaher | 161.58 Bn | 145.40 Bn | 3.61 Bn | 52.59 Bn |
| 4 | Intuitive Surgical | 153.84 Bn | 134.26 Bn | 2.08 Bn | 16.12 Bn |
| 5 | Medtronic | 123.63 Bn | 89.50 Bn | 6.34 Bn | 50.85 Bn |
| 6 | Stryker | 117.79 Bn | 103.90 Bn | 4.50 Bn | 23.99 Bn |
| 7 | Boston Scientific | 66.71 Bn | 61.72 Bn | 3.85 Bn | 25.17 Bn |
| 8 | Becton Dickinson | 54.60 Bn | 51.75 Bn | 2.32 Bn | 24.42 Bn |
| 9 | Edwards Lifesciences | 51.95 Bn | 36.07 Bn | 1.35 Bn | 10.72 Bn |
| 10 | Nephros | 38.23 Mn | 18.94 Mn | 4.03 Mn | 11.97 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 11.97 Mn |
| Mar 31, 2026 | 10.70 Mn |
| Dec 31, 2025 | 10.20 Mn |
| Sep 30, 2025 | 10.01 Mn |
| Jun 30, 2025 | 9.60 Mn |
| Mar 31, 2025 | 9.29 Mn |
| Dec 31, 2024 | 8.59 Mn |
| Sep 30, 2024 | 8.17 Mn |
| Jun 30, 2024 | 7.93 Mn |
| Mar 31, 2024 | 8.18 Mn |
| Dec 31, 2023 | 8.36 Mn |
| Sep 30, 2023 | 8.62 Mn |
| Jun 30, 2023 | 8.66 Mn |
| Mar 31, 2023 | 8.89 Mn |
| Dec 31, 2022 | 8.88 Mn |
| Sep 30, 2022 | 9.58 Mn |
| Jun 30, 2022 | 12.48 Mn |
| Mar 31, 2022 | 13.40 Mn |
| Dec 31, 2021 | 14.75 Mn |
| Sep 30, 2021 | 15.33 Mn |
API Access
Nephros Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=NEPH&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "NEPH", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=NEPH&period=max&api_key=YOUR_API_KEY");
const data = await res.json();